News And Announcements
Ovo ordered to pay £2.4m for customer complaint failings
UK energy supplier Ovo has been ordered to pay £2. 4m in compensation to customers and a government redress fund due to failures customer complaints handling.
W7 owner Warpaint hails another record first half
Cosmetics company Warpaint posted a jump in first-half sales and profit on Tuesday, with a record level of sales delivered at a significantly higher margin.
BAT makes leadership changes as part of 'tobacco harm reduction' focus
British American Tobacco (BAT) announced a number of leadership changes on Tuesday, aimed at accelerating its strategy to build a smokeless future and enhance sustainability.
IP Group NAV falls but sees investor appetite for portfolio
Life sciences investor IP Group reported a wider half-year loss and lower net asset value against what it called a “challenging” economic backdrop but said there were signs that conditions were improving with increase “appetite” for its portfolio.
Revenue rises but losses widen for Comptoir Group
Comptoir Group, the owner and operator of Lebanese, Middle Eastern, and North African-inspired restaurants, reported a 7. 4% increase in group revenue in its interim results on Tuesday, reaching £15. 9m, compared to £14. 8m in the same period last year.
Petershill Partners unveils special divi as first-half profits rise
Private equity group Petershill Partners has reiterated its guidance for 2024 after a solid first half, with double-digit growth in partner fee-related earnings and assets under management, as it announced a special dividend following a recent disposal.
Playtech to sell Italian business to Flutter for €2.3bn
Gambling technology firm Playtech said on Tuesday that it has agreed to sell its Italian business, Snaitech, to Paddy Power owner Flutter Entertainment for €2. 3bn in cash.
Japan to review GSK's Blenrep drug application
Japan's health ministry has accepted for review a new drug application (NDA) for GSK's Blenrep blood cancer treatment, marking the third major regulatory filing acceptance for the drug.